picroside i

Picroside I (6'-Cinnamoylcatalpol), a hepatoprotective agent, is reported to be antimicrobial and used against hepatitis B. It has antioxidant, and anti-inflammatory activities, it may be the valuable anti-invasive drug candidates for cancer therapy by suppressing Collagenases and Gelatinases. Picroside I can enhance basic fibroblast growth factor(bFGF)-, staurosporine- or dbc-mitogen-activated protein (MAP)-induced neurite outgrowth from PC12D cells.

Picroside II (Amphicoside) is a useful organic compound for research related to life sciences and the catalog number is T131515.

Picroside II (Vanilloyl catalpol) is the main active ingredient in iridoid glycosides. It has antioxidant, anti-inflammatory, immune regulatory, anti-virus and other pharmacological activities.

Picroside III is a cyclic enol ether terpene glycoside isolated from the traditional Chinese medicine hu huang lian.Picroside III has the potential to repair intestinal mucosal damage and reduce intestinal inflammation in mice.

Picroside IV is an iridoid glycoside originating from the underground parts of Picrorhiza scrophulariiflora and serves as a derivative of Catalpol while demonstrating broad pharmacological functions including neuroprotective, hypoglycemic, anti-inflammatory, anticancer, antispasmodic, antioxidant, and anti-HBV effects. Picroside IV therefore represents a therapeutically valuable bioactive molecule with high relevance in disease prevention and treatment research.